Andrew G Horti

发表

Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.

Hiroto Kuwabara, Dean F Wong, D. Holt, 2013, Journal of labelled compounds & radiopharmaceuticals.

Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380

Elliot A Stein, John A Matochik, E. Stein, 2008, Journal of Nuclear Medicine.

Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.

Koen Van Laere, K. Van Laere, A. Horti, 2008, Current pharmaceutical design.

Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.

Hiroto Kuwabara, A. Horti, R. Dannals, 2010, Life sciences.

18F-ASEM, a Radiolabeled Antagonist for Imaging the α7-Nicotinic Acetylcholine Receptor with PET

Martin G Pomper, Hiroto Kuwabara, Dean F Wong, 2014, The Journal of Nuclear Medicine.

Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.

A. Horti, Andrew G Horti, 2015, Biochemical pharmacology.

Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging properties.

Hiroto Kuwabara, John Hilton, Dean F Wong, 2008, Journal of medicinal chemistry.

The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.

Victor L Villemagne, A. Horti, V. Villemagne, 2006, Current pharmaceutical design.

11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.

Arman Rahmim, Hiroto Kuwabara, John Hilton, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.

A. Horti, R. Dannals, K. Kellar, 2013, Journal of medicinal chemistry.

Positron emission tomography experience with 2‐[18F]fluoro‐3‐(2(s)‐azetidinylmethoxy)pyridine (2‐[18F]fa) in the living human brain of smokers with paranoid schizophrenia

Yun Zhou, John Hilton, Vanessa Raymont, 2012, Synapse.

Graphical analysis of 2‐[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain

Edythe D London, E. London, A. Horti, 2003, Synapse.

Pharmacological and Toxicological Evaluation of 2-Fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a Ligand for Imaging Cerebral Nicotinic Acetylcholine Receptors with Positron Emission Tomography

Edythe D London, V. O. Wagner, E. London, 2005, Journal of Pharmacology and Experimental Therapeutics.

Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.

A. Hoffman, A. Horti, A. Mukhin, 2003, Journal of medicinal chemistry.